A digital platform to reduce suicide risk in at-risk youth
Development and Testing of a Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
NA · Ksana Health · NCT05920252
This study is testing a new digital platform called Vira to see if it can help reduce suicide risk in teens aged 13-18 who are getting treatment for mental health issues.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 78 (estimated) |
| Ages | 13 Years to 18 Years |
| Sex | All |
| Sponsor | Ksana Health (industry) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05920252 on ClinicalTrials.gov |
What this trial studies
This project aims to address the rising rates of youth suicide by developing a digital platform called Vira, which integrates mobile sensing data and HIPAA-compliant communication tools for practitioners. The study will conduct a randomized controlled trial involving 200 adolescents aged 13-18 who are receiving treatment at the Intensive Adolescent and Family DBT Program. Participants will be divided into two groups: one using the Vira platform and the other receiving standard treatment. The goal is to evaluate whether the use of this digital platform improves clinical outcomes for youth at risk of suicide.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 13-18 who are currently receiving treatment at the Intensive Adolescent and Family DBT Program and own a personal smartphone.
Not a fit: Patients who require a higher level of care or those already assigned a clinician in the program may not benefit from this study.
Why it matters
Potential benefit: If successful, this platform could significantly enhance the effectiveness of suicide prevention strategies for at-risk youth.
How similar studies have performed: Other studies have shown promise in using digital tools for mental health interventions, suggesting potential success for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed assent from adolescents ages 13-17 years old and permission from legal guardians, or consent from adolescents age 18 years old. * Receiving treatment at the Intensive Adolescent and Family DBT Pgogram * 13-18 years old * Owns a personal smartphone (Android or iPhone 7+) * Fluent in English Exclusion Criteria: * Adolescents who require a higher level of care (i.e., are not admitted to the Intensive Outpatient DBT program) * Adolescents who are receiving treatment at the Intensive Adolescent and Family DBT program and have already been assigned a clinician
Where this trial is running
New York, New York
- Columbia University — New York, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Nick Allen, PhD — Ksana Health
- Study coordinator: Randy Auerbach, PhD, ABPP
- Email: rpa2009@cumc.columbia.edu
- Phone: 646-774-5745
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Suicide, Mental Health Disorder, Anhedonia, Depression, Depressive Disorder, Mood Disorders, Mental Disorders, Suicidal Behaviors